Lode-Star Mining Inc. Appoints Samuel Sternheim as Chief Financial Officer
a director of Sapir Pharmaceuticals, and has been CFO of Sapir since 2015, where he has overseen fundraising,
numerous acquisitions and licensing ventures globally.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.024 USD | 0.00% |
|
0.00% | +20.00% |
05-15 | Lode-Star Mining Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-22 | Lode-Star Mining Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+20.00% | 2.9M | |
+3.43% | 49.37B | |
+20.46% | 32.98B | |
-3.05% | 29.74B | |
+12.82% | 24.41B | |
+0.18% | 10.29B | |
+26.91% | 9.9B | |
-.--% | 9.07B | |
+31.30% | 9.45B | |
+3.06% | 8.19B |